Skip to main content
. 2017 Aug 12;3(1):73–80. doi: 10.1016/j.ekir.2017.08.003

Figure 2.

Figure 2

Changes in mean serum phosphate levels (n = 16) from screening to end of treatment. Note that serum phosphate levels increased after washout of phosphate-binding therapy up to the day of randomization (day 0); however, no reduction in serum phosphate levels occurred during the active treatment period with ASP3325 (days 0–14).